In vitro infection of human peripheral blood mononuclear cells by a defective hepatitis B virus with a deletion in the PreS1 region of the viral genome

Journal of Viral Hepatitis

Volumn 9, Issue 4, 2002, Pages 265-271

  Cabrerizo, M ^a   Bartolome J ^a   Carreño, Vicente ^a  

^a Hospital Pardo de Aravaca   (Spain)

Author keywords

Cell cultures; Covalently closed circular HBV DNA; HBV RNA; Occult HBV infection

Indexed keywords

CIRCULAR DNA; DEOXYRIBONUCLEASE; HEPATITIS B ANTIGEN; TRYPSIN; VIRUS DNA; VIRUS RNA;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELETION MUTANT; DNA DETERMINATION; GENE DELETION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUPERNATANT; VIRUS CARRIER; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELLS, CULTURED; DEFECTIVE VIRUSES; GENE DELETION; GENOME, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LEUKOCYTES, MONONUCLEAR; PROTEIN PRECURSORS;

EID: 0036904059     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00367.x     Document Type: Article

References (31)

1. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 1990; 12: 204-212.
2. Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14: 56-62.
3. Michalak TI, Pasquinelli C, Guihot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93: 230-239.
4. Oesterreicher C, Hammer J, Koch U et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic haemodialysis. Kidney Int 1995; 48: 1967-71.
5. Yotsuyanagi H, Yasuda K, Iino S et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1997; 27: 1377-1382.
6. Cabrerizo M, Bartolomé J, de Sequera P, Caramelo C, Carreño V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative haemodialysis patients and staff. J Am Soc Nephrol 1997; 8: 1443-1447.
7. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998; 27: 1736-1742.
8. Thiers V, Nakajima E, Kremsdorf D et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988; 2: 1273-1276.
9. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990; 30: 431-432.
10. Chazouillères O, Mamish D, Kim M et al. 'Occult' hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343: 142-146.
11. Wachs ME, Amend WJ, Ascher NL et al. The risk of transmission of hepatitis B from HBsAg(-), HbcAb(+), HbigM(-) organ donors. Transplantation 1995; 59: 230-234.
12. Lowell JA, Howard TK, White HM et al. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet 1995; 345: 1084-1085.
13. Cabrerizo M, Bartolomé J, Caramelo C, Barril G, Carreño V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B antigen-negative cases. Hepatology 2000; 32: 116-123.
14. Raney AK, Le HB, McLachlan A. Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol 1996; 66: 6912-6921.
15. Lu CC, Yen TSB. Activation of the hepatitis B virus S promoter by transcription factor NF-Y via a CCAAT element. Virology 1996; 225: 387-394.
16. Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: Domain structure and RNase H activity. J Virol 1990; 64: 613-620.
17. Melegari M, Bruno S, Wands JR. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 1994; 199: 292-300.
18. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967; 26: 365-369.
19. Kwok S, Higuchi R. Avoiding false positive with PCR. Nature 1989; 339: 237-238.
20. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. The complete nucleotide sequence of the cloned hepatitis B virus DNA. Subtype adr and adw. Nucleic Acids Res 1983; 11: 1747-1757.
21. Coffin CS, Michalak TI. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 1999; 104: 203-212.
22. Michalak TI, Pardoe LU, Coffin CS et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29: 928-938.
23. Cacciola I, Pollicino T, Squadrito G, Cerencia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis B liver disease. N Engl J Med 1999; 341: 22-26.
24. Fukuda R, Ishimura N, Hamamoto S et al. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by donor-regulation of type I interferon receptor gene expression in the liver. J Med Virol 2001; 63: 220-227.
25. Paterlini P, Gerken G, Nakajima E et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80-85.
26. Gerken G, Kremsdorf D, Chapel F et al. Hepatitis B defective virus with rearrangements in the pre-S gene during chronic HBV infection. Virology 1991; 183: 555-565.
27. Nakajima E, Minami M, Ochiya T, Kagawa K, Okochi K. PreS1 defected variants of hepatitis B virus in patients with chronic hepatitis. J Hepatol 1994; 20: 329-335.
28. Galun E, Nahor O, Eid A et al. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. Virology 2000; 270: 299-309.
29. Lew YY, Michalak TI. In vitro and in vivo infectivity and pathogenicity of the lymphoid-cell-derived woodchuck hepatitis virus. J Virol 2001; 75: 1770-1782.
30. Persing DH, Varmus HE, Ganem D. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 1986; 234: 1388-1391.
31. Chisari FV, Filippi P, Buras J et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987; 84: 6909-6913.